Status:
UNKNOWN
Diagnostic Performance Assessment of Qualitative Ifobt and Quantitative Ifobt for Advanced Neoplastic
Lead Sponsor:
CECILIA CURVALE
Collaborating Sponsors:
Ministry of Public Health, Argentina
Conditions:
Colorectal Neoplasms
Eligibility:
All Genders
50-75 years
Brief Summary
In Argentina, there is vast experience in qualitative iFOBT population screening that is part of the CRC Prevention and Early Detection National Program. The screening's cut-off point is at 50 ng/mL b...
Eligibility Criteria
Inclusion
- men and women aged 50-75
- Hospital El Cruce's coverage area and
Exclusion
- those that have taken part in a previous VCC screening in the 5 past years or in a CRC screening program the year before the recruitment
- personal history of colorectal cancer or inflammatory bowel disease, personal or family history of syndromes of predisposition to known cancers, or family history of colorectal cancer in a first-degree relative aged less than 60
- those refuse to sign the consent form to take part in this study
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
630 Patients enrolled
Trial Details
Trial ID
NCT04831632
Start Date
May 1 2021
End Date
December 31 2022
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital El Cruce
San Juan Bautista, Buenos Aires, Argentina, 1888